(Q34332119)

English

Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapy

scientific article

Statements

Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapy (English)
Murugappan Ramanathan
Geoffrey R Deschenes
Raphaelle El Habib

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit